Skip to content

Evaluation of Technological Innovation in Radiotherapy

Cancer | Radiotherapy Side Effect

Prospective cohort study of patients receiving standard-care radiotherapy is paramount to a better understanding of radiation effects and longterm outcomes.

The primary objective is to determine the feasibility of establishing infrastructure to systematically collect clinical data, patient-reported outcomes, and imaging data from daily radiotherapy practice.

Secondary objectives are to provide a control cohort for comparative effectiveness research of investigational interventions through a cmRCT design; compare imaging features with clinical outcomes; understand dose-effect relationships; quantify imaging quality metrics.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Ability to provide informed consent
* Receiving radiotherapy or brachytherapy

Exclusion Criteria:

-

Study Location

London Health Regional Cancer Centre
London Health Regional Cancer Centre
London, Ontario
Canada

Contact Study Team

Primary Contact

Karen Eddy

[email protected]
CHUQ
CHUQ
Québec, Quebec
Canada

Contact Study Team

Primary Contact

Sophie Pouliot

[email protected]
4185254444
Centre Hospitalier de l'Université de Montréal
Centre Hospitalier de l'Université de Montréal
Montréal, Quebec
Canada

Contact Study Team

Primary Contact

Diane Trudel

[email protected]
514-890-8000
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Philip Wong

[email protected]
Centre de santé et de services sociaux de Laval
Centre de santé et de services sociaux de Laval
Laval, Quebec
Canada

Contact Study Team

Primary Contact

Marie-Andrée Fortin, MD

Study Sponsored By
Centre hospitalier de l'Université de Montréal (CHUM)
Participants Required
More Information
Study ID: NCT03378856